The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Open accessAbstract
Summary: The purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long‐term efficacy or effectiveness for antiepileptic drugs (AED s) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from J uly 2005 until M arch 2012 were identified, evaluated, and combined with the previous analysis (Glauser et al., 2006) to provide a comprehensive update. The prior analysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were analyzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations. This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent‐to‐treat analysis. Since J uly, 2005, three class I randomized controlled trials (RCT) and 11 class III RCT s have been published. The combined analysis (1940–2012) now includes a total of 64 RCT s (7 with class I evidence, 2 with class II evidence) and 11 meta‐analyses. New efficacy/effectiveness findings include the following: levetiracetam and zonisamide have level A evidence in adults with partial onset seizures and both ethosuximide and valproic acid have level A evidence in children with childhood absence epilepsy. There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for adults with partial onset seizures. Although ethosuximide and valproic acid now have level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCT s for patients with generalized seizures/epilepsies and in children in general. These findings reinforce the need for multicenter, multinational efforts to design, conduct, and analyze future clinically relevant adequately designed RCT s. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattson, R. H., Cramer, J. A., Collins, J. F., Smith, D. B., Delgado-Escueta, A. V., Browne, T. R., Williamson, P. D., Treiman, D. M., McNamara, J. O., McCutchen, C. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130303 · Cited by 1,138
Self-citationMarson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., & Tomson, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00585.x · Cited by 790
Self-citationMattson, R. H., Cramer, J. A., & Collins, J. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271104 · Cited by 683
Self-citationEthosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Capparelli, E. V., & Adamson, P. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902014 · Cited by 645
Self-citationDouble-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 615
New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine
Rowan, A. J., Ramsay, R. E., Collins, J. F., Pryor, F., Boardman, K. D., Uthman, B. M., Spitz, M., Frederick, T., Towne, A., Carter, G. S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167384.68207.3e · Cited by 509
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
Brodie, M. J., Perucca, E., Ryvlin, P., Ben-Menachem, E., & Meencke, H.-J. (2007) · Neurology · doi:10.1212/01.wnl.0000252941.50833.4a · Cited by 467
Self-citationBrodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 459
Research works printed but not linked: 14
- Bourgeois B, 1998, Gabapentin(Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes(BECTS): a 36‐week, double‐blind, placebo‐controlled study, Epilepsia, 39, 163
- 10.1111/j.0013-9580.2004.40903.x · doi:10.1111/j.0013-9580.2004.40903.x
- 10.1016/j.seizure.2011.04.005 · doi:10.1016/j.seizure.2011.04.005
- 10.1212/01.wnl.0000210517.03902.6e · doi:10.1212/01.wnl.0000210517.03902.6e
- 10.1136/jnnp.45.12.1113 · doi:10.1136/jnnp.45.12.1113
- Loiseau P, 1984, [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine], Rev Neurol, 140, 434
- Martinovic Z, 1983, Advances in epileptology, XIVth epilepsy international symposium, 301
- Posner E, Absence seizures in children, Clin Evid
- Rastogi P, 1991, Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy, J Assoc Physicians India, 39, 606
- 10.1111/j.1528-1157.1981.tb04330.x · doi:10.1111/j.1528-1157.1981.tb04330.x
- Sobaniec W, 2005, A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children, Pharmacol Rep, 57, 646
- 10.1001/archneurpsyc.1940.02280010078005 · doi:10.1001/archneurpsyc.1940.02280010078005
- 10.1016/S0920-1211(96)00074-5 · doi:10.1016/s0920-1211(96)00074-5
- 10.1177/088307389601100611 · doi:10.1177/088307389601100611
Cited by
Chen, Z., Brodie, M. J., Liew, D., & Kwan, P. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3949 · Cited by 1,514
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Seizures and Epilepsy: An Overview for Neuroscientists
Stafstrom, C. E., & Carmant, L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022426 · Cited by 933
Moshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Self-citationNew avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Löscher, W., & Klein, P. (2021) · CNS Drugs · doi:10.1007/s40263-021-00827-8 · Cited by 367
Drug treatment of epilepsy in adults
Schmidt, D., & Schachter, S. C. (2014) · BMJ · doi:10.1136/bmj.g254 · Cited by 323
Manford, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8394-2 · Cited by 299
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
Fattorusso, A., Matricardi, S., Mencaroni, E., Dell'Isola, G. B., Di Cara, G., Striano, P., & Verrotti, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.674483 · Cited by 269
Tomson, T., Battino, D., & Perucca, E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00314-2 · Cited by 266
Self-citation30 years of second-generation antiseizure medications: impact and future perspectives
Perucca, E., Brodie, M. J., Kwan, P., & Tomson, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30035-1 · Cited by 261
Self-citation(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802997-8.00016-5 · Cited by 244
Wang, Y., Ying, X., Chen, L., Liu, Y., Wang, Y., Liang, J., Xu, C., Guo, Y., Wang, S., Hu, W., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0431-9 · Cited by 65
Zhang, Y.-J., Guo, Y.-Y., & Wang, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-52532-5 · Cited by 3
“…item pool was generated based on a systematic review of common epilepsy treatment misconceptions documented in the clinical literature 8,31,32 and a preliminary screening of 50 epilepsy-related videos (not included in the final sample) to identify recurring patterns of treatment…”
Metadata
- Authors
- Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J. A., Perucca, E., Tomson, T., & Guidelines, F. T. I. S. O. A.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2013-01-25
- Volume
- 54
- Issue
- 3
- Pages
- 551-563
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2143243043
- Cited by
- 721
- References
- 65
- FWCI
- 38.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.